56

Barriers Sub-sector specific barriers (Annex 8) and barriers common to all sub-sectors were identified during the literature review and desk-based research phase of the study. The barriers common to all Blue Biotechnology sub-sectors were presented to stakeholders at the project’s Stakeholder Workshop and stakeholders were asked to prioritise them (see Section 3.1.8). In addition, the European Commission’s public consultation on Blue Biotechnology (Annex 9) presented a number of perceived barriers relating to bringing marine biotechnology applications into the market and the perceived challenges encountered in research. Stakeholders were asked to rank these barriers. Table 3.9 presents the barriers identified in the literature review and additional barriers identified at the workshop and during the public consultation. Throughout stakeholder discussions it was evident that there is a high degree of interconnectedness between the barriers. 34 Study in support of Impact Assessment work on Blue Biotechnology Table 3.9 Type of barrie Coordination Finance Knowledge

57 Publizr Home